Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · Real-Time Price · USD
4.510
+0.110 (2.50%)
Jan 22, 2025, 10:42 AM EST - Market open
Adverum Biotechnologies Employees
Adverum Biotechnologies had 121 employees as of December 31, 2023. The number of employees decreased by 2 or -1.63% compared to the previous year.
Employees
121
Change (1Y)
-2
Growth (1Y)
-1.63%
Revenue / Employee
$8,264
Profits / Employee
-$777,777
Market Cap
93.82M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
ADVM News
- 6 weeks ago - Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Adverum Biotechnologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Adverum: Ixo-Vec Could Reduce Treatment Burden For Wet-AMD Patients - Seeking Alpha
- 2 months ago - Adverum Biotechnologies Announces Webcast to Report 52-Week LUNA Phase 2 Clinical Data and 4-Year OPTIC Clinical Data, and to Provide Key Pivotal Program Design Elements - GlobeNewsWire
- 2 months ago - Adverum Biotechnologies Reports Third Quarter 2024 Financial Results, Provides Corporate Highlights and Updates Anticipated Milestones - GlobeNewsWire
- 3 months ago - Adverum Biotechnologies Appoints Jason L. Mitchell as Chief Commercial Officer as it Prepares to Initiate Pivotal Program - GlobeNewsWire
- 4 months ago - Adverum Biotechnologies to Participate in Upcoming Fall Investor Conferences - GlobeNewsWire
- 6 months ago - Adverum Biotechnologies to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference - GlobeNewsWire